AnaptysBio, Inc. (ANAB) Earnings
|
Expand Research on ANAB
| Next EPS Date | 8/7/26 *Est. | EPS Growth Rate | +100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +37.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/26 |
Q126 | N/A | -$0.87 | N/A | N/A | $22.47M | N/A | N/A | N/A | ||
| 3/3/26 |
Q425 | $1.58 | $0.87 | +$0.71 | $108.25M | $87.09M | N/A | ![]() | ![]() | Details | |
| 11/11/25 |
Q325 | N/A | -$1.40 | N/A | N/A | $15.85M | N/A | N/A | N/A | ||
| 8/7/25 |
Q225 | -$1.34 | -$1.52 | +$0.18 | $22.26M | $11.51M | N/A | ![]() | ![]() | Details | |
| 5/5/25 |
Q125 | -$1.28 | -$1.30 | +$0.02 | N/A | $13.7M | N/A | ![]() | ![]() | Details | |
| 2/27/25 | Q424 | -$0.72 | -$1.62 | +$0.90 | $43.11M | $8.44M | N/A | ![]() | ![]() | Details | |
| 11/5/24 | Q324 | -$1.14 | -$1.70 | +$0.56 | $30.02M | $6.92M | N/A | ![]() | ![]() | Details | |
| 8/5/24 | Q224 | -$1.71 | -$1.04 | -$0.67 | $10.97M | $22.76M | N/A | ![]() | ![]() | Details |


